Showing results (451-460 of 501) with videos related to
Sort By:
Pageof 51
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.Cancer Cell|July 16, 2015
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and MetastasisJonathan F Goodwin, Vishal Kothari, Justin M Drake, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate CancerWilliam S Chen, Winston A Haynes, Rebecca Waitz, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.European Urology|May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate CancerAmar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.Cell Reports. Medicine|October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.European Urology Oncology|February 1, 2024
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 TrialAshley E Ross, Jingbin Zhang, Huei-Chung Huang, et al.NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.Pageof 51